The Future of HIV-1 Therapeutics Resistance Is Futile? /

This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Torbett, Bruce E. (Επιμελητής έκδοσης), Goodsell, David S. (Επιμελητής έκδοσης), Richman, Douglas D. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
Σειρά:Current Topics in Microbiology and Immunology, 389
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • HIV Therapy ­ Looking Towards the Future
  • Computational challenges of structure-based approaches applied to HIV
  • Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1
  • HIV-1 integrase multimerization as a therapeutic target
  • Targeting HIV transcription: The quest for a functional cure
  • Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder
  • HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
  • The Triple Threat of HIV-1 Protease Inhibitors
  • Illustrations of the HIV Life Cycle.